Tax
Income Tax
Vertex Pharmaceuticals Income Tax decreased by 35.2% to $139.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 37.4%, from $223.50M to $139.90M. Over 4 years (FY 2021 to FY 2025), Income Tax shows an upward trend with a 15.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionTax
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Changes may reflect shifts in corporate tax law, geographic earnings mix, or the expiration of tax incentives.
Detailed definition
The total amount of income tax a company expects to pay to federal, state, and foreign governments based on its earnings...
Peer comparison
Global companies often have complex tax expenses due to earnings in multiple international jurisdictions.
Metric ID:
is_income_tax_expenseHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$111.18M | $230.81M | $100.84M | $192.70M | $213.90M | $245.90M | $257.90M | $191.70M | $245.80M | $143.90M | $178.80M | $179.50M | $202.40M | $178.70M | $223.50M | $84.10M | $250.10M | $215.90M | $139.90M |
| QoQ Change | — | +307.6% | -56.3% | +91.1% | +11.0% | +15.0% | +4.9% | -25.7% | +28.2% | -41.5% | +24.3% | +0.4% | +12.8% | -11.7% | +25.1% | -62.4% | +197.4% | -13.7% | -35.2% |
| YoY Change | — | — | — | — | +292.4% | +6.5% | +155.7% | -0.5% | +14.9% | -41.5% | -30.7% | -6.4% | -17.7% | +24.2% | +25.0% | -53.1% | +23.6% | +20.8% | -37.4% |
Range-$111.18M – $257.90M
CAGR+5.2%
Avg YoY Growth+25.1%
Median YoY Growth+6.5%
Current Streak2 quarters decline
Business Segments
Loading segment data...
Income Tax at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's income tax?
- Vertex Pharmaceuticals (VRTX) reported income tax of $139.90M in Q4 2025.
- How has Vertex Pharmaceuticals's income tax changed year-over-year?
- Vertex Pharmaceuticals's income tax decreased by 37.4% year-over-year, from $223.50M to $139.90M.
- What is the long-term trend for Vertex Pharmaceuticals's income tax?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's income tax has grown at a 15.5% compound annual growth rate (CAGR), from $388.30M to $690.00M.
- What does income tax mean?
- The amount of money a company sets aside to pay its corporate income taxes.